Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Hoth Therapeutics stock
Learn how to easily invest in Hoth Therapeutics stock.
Hoth Therapeutics Inc is a biotechnology business based in the US. Hoth Therapeutics shares (HOTH) are listed on the NASDAQ and all prices are listed in US Dollars. Hoth Therapeutics employs 3 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Hoth Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – HOTH – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Hoth Therapeutics stock price (NASDAQ: HOTH)Use our graph to track the performance of HOTH stocks over time.
Hoth Therapeutics shares at a glance
|Latest market close||$0.81|
|52-week range||$0.64 - $3.50|
|50-day moving average||$0.88|
|200-day moving average||$1.28|
|Wall St. target price||$3.88|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.59|
Buy Hoth Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Hoth Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Hoth Therapeutics price performance over time
|1 week (2022-01-07)||-14.98%|
|1 month (2021-12-16)||15.22%|
|3 months (2021-10-15)||-30.17%|
|6 months (2021-07-16)||-41.30%|
|1 year (2021-01-15)||-63.18%|
|2 years (2020-01-17)||-83.85%|
|3 years (2019-01-13)||N/A|
|5 years (2017-01-13)||N/A|
Hoth Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-68.15%|
|Return on equity TTM||-123.81%|
|Market capitalisation||$22.8 million|
TTM: trailing 12 months
Hoth Therapeutics share dividends
We're not expecting Hoth Therapeutics to pay a dividend over the next 12 months.
Hoth Therapeutics share price volatility
Over the last 12 months, Hoth Therapeutics's shares have ranged in value from as little as $0.635 up to $3.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Hoth Therapeutics's is 0.9852. This would suggest that Hoth Therapeutics's shares are less volatile than average (for this exchange).
Hoth Therapeutics overview
Hoth Therapeutics, Inc. , a biopharmaceutical company, focuses on developing therapies for dermatological disorders. The company focuses on therapies for patients suffering from indications, including eczema, chronic wounds, psoriasis, asthma, and acne. Its pipeline portfolio includes HT-001, a topical formulation for the treatment of mild to moderate rash and skin disorders associated with initial and repeat courses of tyrosine kinase inhibitor/epidermal growth factor receptor (EGFR) inhibitor therapy; HT-002 to treat illness associated with SARS-CoV-2 infection; HT-003D for the topical treatment in acne and psoriasis applications; HT-003IB to treat inflammatory bowel diseases; HT-004 for the treatment of asthma, atopic dermatitis, and other allergic diseases; HT-005 Z-PODS to treat cutaneous lupus erythematosus; HT-006 for treatment of multiple bacterial pathogens. The company has license agreements with the George Washington University; the University of Maryland; Isoprene Pharmaceuticals, Inc. ; the North Carolina State University; Chelexa BioSciences, Inc. ; and the University of Cincinnati.
Hoth Therapeutics in the news
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Two of Sen. Kyrsten Sinema's former aides have lobbied for corporate giants looking to influence Joe Biden's agenda
Hoth Therapeutics Inc Shares Close the Week 44.4% Higher - Weekly Wrap
Frequently asked questionsWhat percentage of Hoth Therapeutics is owned by insiders or institutions?
Currently 16.408% of Hoth Therapeutics shares are held by insiders and 13.08% by institutions. How many people work for Hoth Therapeutics?
Latest data suggests 3 work at Hoth Therapeutics. When does the fiscal year end for Hoth Therapeutics?
Hoth Therapeutics's fiscal year ends in December. Where is Hoth Therapeutics based?
Hoth Therapeutics's address is: 1 Rockefeller Plaza, New York, NY, United States, 10020 What is Hoth Therapeutics's ISIN number?
Hoth Therapeutics's international securities identification number is: US44148G1058 What is Hoth Therapeutics's CUSIP number?
Hoth Therapeutics's Committee on Uniform Securities Identification Procedures number is: 44148G105
More guides on Finder
Donut savings review
Donut earns up to 10% APY, but you must have an iOS device.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
How to buy VinFast stock when it goes public
Everything we know about the VinFast IPO, plus information on how to buy in.
NFT-funded LinksDAO moves $10.5 million closer to buying a golf course
Creating a golf club is a thus-far unique application of NFTs, and another step forward for the decentralized economy.
How to buy Nexalin Technology (NXL) stock when it goes public
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.
How to buy Specialty Building Products (SBP) stock when it goes public
Everything we know about the Specialty Building Products IPO, plus information on how to buy in.
How to buy HeartCore Enterprises (HTCR) stock when it goes public
Everything we know about the HeartCore Enterprises IPO, plus information on how to buy in.
Ask an Expert